Navigation Links
Phase I Research of Extended-Release Topiramate Shows Less Fluctuation in Plasma Levels
Date:4/11/2011

Extended-Release Formulation of Topiramate) and its Lack of Food-Effect." Authors: Lawrence J. Lambrecht, Wesley M. Todd, Mark B. Halvorsen.

The studies that are the subjects of these posters have been conducted by Upsher-Smith to characterize the pharmacokinetic profile of USL255.  The first poster presented data from numerous internally developed topiramate ER formulations.  The objective of the research presented was to identify a once daily ER formulation with a lower maximum plasma concentration, a higher trough concentration, and an equivalent extent of exposure as compared to IR topiramate.  The PK data from the experimental formulations were compared to IR topiramate, after single doses and/or at simulated steady-state.  Results have aided USL researchers in the formulation selection for USL255.

In another study and second poster presentation, the effect of food on the bioavailability of USL255 was assessed.  In this Phase I, randomized, single-dose, crossover study, 36 healthy subjects received three different treatments (200 mg of USL255 under fasting conditions; 200 mg of USL255 with a high fat meal; or 2 doses of 100 mg IR topiramate dosed 12 hours apart).  Based on PK measurements and using standard bioequivalence criteria, the authors determined that the overall extent of absorption of USL255 was not affected by food. However, the presence of food was associated with a delay in the time to maximal plasma concentration of topiramate, a finding that was deemed consistent with the food effect on IR topiramate pharmacokinetics.  

The second poster also compared two 100 mg doses of IR topiramate (administered 12 hours apart) and a single 200 mg dose of USL255 for pharmacokinetic equivalence, using standard bioequivalence criteria.  The authors reported that administration of 200 mg of USL255 in healthy volunteers provided equivalent topiramate exposure as compared with t
'/>"/>

SOURCE Upsher-Smith Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. QNEXA® Phase 3 Data in The Lancet Show Significant Weight Loss and Broad Improvements in Co-Morbidities
2. Update on Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710
3. Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
4. Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results
5. Jennerex and Transgene Announce Presentation of Phase 1 Data Demonstrating that JX-594 Administration Targets Tumor Vasculature
6. BioDelivery Sciences Announces Completion of Recruitment in BEMA Buprenorphine Phase 3 Chronic Pain Study
7. Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System
8. Positive Phase 2 Results Reported with Boehringer Ingelheims Investigational HCV Protease Inhibitor in Both Previously Treated and Untreated Patients
9. Omeros Reports Outcome of Phase 3 Trials of OMS103HP
10. Conatus Pharmaceuticals Presents Results From a Phase 2 Clinical Trial of CTS-1027 in HCV Genotype 1 Null-Responders
11. Intercept Pharmaceuticals Announces Positive Phase II Results for Obeticholic Acid (INT-747) as Monotherapy in Primary Biliary Cirrhosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... CITY, Calif. , Nov. 26, 2014  Genomic ... Kim Popovits , Chairman, Chief Executive Officer and ... Piper Jaffray Healthcare Conference at The New York Palace ... Wednesday, December 3 at 11:30 am Eastern Time (ET). ... webcast of the conference call, go to the  Investor ...
(Date:11/26/2014)... , November 26, 2014 Investor-Edge has ... VVUS ), Horizon Pharma PLC (NASDAQ: HZNP ... Johnson (NYSE: JNJ ), and Theravance Inc. (NASDAQ: ... can be accessed at: http://investor-edge.com/register . On ... up 0.07%, the Dow Jones Industrial Average edged 0.02% lower, ...
(Date:11/26/2014)... , Nov. 26, 2014  CARsgen, a leader in ... immunotherapy to treat a variety of cancers, today announced ... BVCF, a China -based healthcare private ... company focused on the development of new therapeutics for ... Shanghai Cancer Institute and Shanghai Renji Hospital, the company ...
Breaking Medicine Technology:Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5CARsgen Completes Series A Financing 2
... 25, 2011 Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ... John H. Johnson as Chief Executive Officer, effective January 31, ... Savient,s board of directors. Mr. Johnson brings significant ... a Senior Vice President of Eli Lilly and Company and ...
... recently launched eCS Inpatient EHR V1.2 (eCS), the first ... medium hospitals. eCS,s uniqueness is the tight linkage of ... a single web-based software solution. The solution is offered ... simplified deployment. "eCS is an affordable solution ...
Cached Medicine Technology:Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer 2Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer 3Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer 4eCareSoft Launches Comprehensive EHR for Small & Medium Hospitals 2
(Date:11/28/2014)... 28, 2014 Nipomo Family Dentistry ... Do, recently opened its doors at 195 N. Thompson ... with preventative care like teeth cleanings, oral exams, fillings, ... Invisalign, teeth whitening (and Kor whitening), laser whitening, gum ... Nipomo Family Dentistry’s five-person team also takes a philanthropic ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 ... is lowering prices and offering savings in abundance ... hair care, hair loss and cosmetic products such ... and Bosley, TheBeautyPlace.com offers competitive discounts on already ... sold at affordable prices giving customers savings year ...
(Date:11/27/2014)... 2014 Ericdress.com today announced a ... up to 85% off, on all its clothing, shoes and ... Dec. 1 – 7, 2014 only. , At the special ... Orders above $109 can enjoy an extra $10 discount. Moreover, ... The business specially recommended its new collection of 2015 evening ...
(Date:11/27/2014)... knows, Cyber Monday is a crazy shopping day. Owing to ... now providing many big promotions on its website. Customers can ... current prices. The discount are up to 80% off. So ... orders above $88) from Dec. 1 – 4 2014. , ... are willing to shop on the internet. As a leading ...
(Date:11/27/2014)... Recently, DressVe , the well-known trendy young women’s clothing ... valid during Nov. 29 – Dec. 3 2014. In the ... up to 90% off. In addition, free delivery is provided ... http://www.dressve.com/ , Dresses that combine trendy styles and ... somebody’s personality and figure. The designers of DressVe.com know this ...
Breaking Medicine News(10 mins):Health News:Nipomo Family Dentistry Opens New Dental Office in Nipomo 2Health News:Nipomo Family Dentistry Opens New Dental Office in Nipomo 3Health News:TheBeautyPlace.com Announces Double Savings 2Health News:Ericdress.com Special Monday Sales Are Ready For Everyone 2Health News:Tidebuy.com Launching Overcoats Sales for the Special Monday in 2014 2Health News:DressVe.com Introduces Its 2014 Special Monday Sales To The Global Customers 2
... TUESDAY, Jan. 25 (HealthDay News) -- It,s hard to help ... long-term is even tougher. But obese children whose parents took ... weight and kept it off for the next two years, ... study shows that targeting parents -- rather than the children ...
... a friendly bartender can be the source of more than ... suggests that some bartenders may be in a good position ... help connect them to the appropriate agency. Researchers at ... Foreign Wars posts in Ohio. The results showed that ...
... Colo. (Jan. 25, 2011) A new study led ... at The Children,s Hospital and Colorado Health Outcomes Program ... explores the barriers, facilitators and alternative approaches to providers ... immunization registry. Reminder or recall messages, usually in the ...
... by further developing a culture of safety in which all ... can work together to maximize safety, according to an invited ... (PRO), a new medical journal whose mission is to ... official journal of the American Society for Radiation Oncology (ASTRO). ...
... 25 (HealthDay News) -- Epilepsy was the likely cause of ... to a new study. Researchers reached the conclusion that ... descriptions of his hallucinations -- including his description of a ... life written by pupils and friends such as George Sand. ...
... cardiovascular surgery, resulting in elevated circulating levels of cell-free ... and gut wall integrity is unclear. A research ... the World Journal of Gastroenterology addresses this ... levels similar to those found during cardiovascular surgery. The ...
Cached Medicine News:Health News:Changing Parental Behavior May Help Obese Kids Lose Weight 2Health News:Changing Parental Behavior May Help Obese Kids Lose Weight 3Health News:Bartenders may have role in assisting troubled war veterans 2Health News:Bartenders may have role in assisting troubled war veterans 3Health News:New study finds reminders for immunizations challenging for pediatric practices 2Health News:New study finds reminders for immunizations challenging for pediatric practices 3Health News:Culture of safety key to reducing chances for medical errors 2
Transcranial vascular DWL doppler....
The Natural Selection family of specialty allografts is spinal concepts response to surgeon requests for spinal allograft devices to eliminate the need for painful autograft harvesting....
Transcranial vascular DWL doppler....
Transcranial vascular DWL doppler....
Medicine Products: